chartexchange

Akebia Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights

GlobeNewswire Inc. | Nov 5, 2026 7:10 AM EST

Patients on Vafseo® (vadadustat) increased to approximately 11,500 at the end of Q3 2026 representing an increase of approximately 140% from the end of Q3 2025 

Read original article